Huizenga Capital Management logo

Huizenga Capital Management

North America, Illinois, United States, Oak Brook

Description

Huizenga Capital Management is an investment management company that specializes in oversees investments.

Investor Profile

Huizenga Capital Management has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series C (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • 3d Printing
  • Advanced Materials
  • Handmade
  • Industrial Manufacturing
  • Manufacturing
  • Retail
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Huizenga Capital Management frequently co-invest with?

IDEA Fund Partners
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
Breakout Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
MA
North America, Illinois, United States, Chicago
Co-Investments: 1
Monashee Investment Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
OCA Ventures
North America, Illinois, United States, Chicago
Co-Investments: 1
Trinitas Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
MV
North America, California, United States, San Francisco
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Huizenga Capital Management?

HiberCell

New York, New York, United States

HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BMay 19, 2021
Amount Raised: $67,400,000
Cortexyme

South San Francisco, California, United States

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 31, 2018
Amount Raised: $76,000,000
Impossible Objects

Northbrook, Illinois, United States

Impossible Objects is a developer of a 3D printing technology used to make objects from sheets of kevlar, carbon fiber, and fiberglass.

3D PrintingAdvanced MaterialsHandmadeIndustrial ManufacturingManufacturingRetail
Series AOct 10, 2017
Amount Raised: $6,400,000
Eved

Chicago, Illinois, United States

Global AP & Payments Platform for Events, Media and Entertainment.

E-CommerceEvent ManagementEventsPaymentsProcurement
Series CDec 16, 2015
Amount Raised: $14,300,000